Payment overview · 2025
General Payments
$227.20
2 reported records · 2 companies
Healthcare provider profile · identity verified
Beverly Spaulding Gutierrez, M.D.
Allopathic & Osteopathic Physicians|Preventive Medicine|Occupational Medicine · SAN ANTONIO, TX · NPI 1023057528
Verified facts
What the public records show
CMS Open Payments records show Beverly Spaulding Gutierrez, M.D. received $227.20 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 54.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nuplazid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Nuplazid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $124.32 | 54.7% | 1 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $102.88 | 45.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $227.20 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $124.32 | 1 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $102.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 36 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
36 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 966 | 167 |
| Gabapentin | Gabapentin | 651 | 113 |
| Amlodipine Besylate | Amlodipine Besylate | 587 | 101 |
| Eliquis | Apixaban | 545 | 65 |
| Sertraline Hcl | Sertraline Hcl | 488 | 69 |
| Donepezil Hcl | Donepezil Hcl | 458 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 442 | 93 |
| Trazodone Hcl | Trazodone Hcl | 429 | 77 |
| Metoprolol Tartrate | Metoprolol Tartrate | 421 | 76 |
| Furosemide | Furosemide | 420 | 102 |
| Lisinopril | Lisinopril | 414 | 90 |
| Tamsulosin Hcl | Tamsulosin Hcl | 395 | 67 |
| Mirtazapine | Mirtazapine | 375 | 63 |
| Potassium Chloride | Potassium Chloride | 371 | 63 |
| Metformin Hcl | Metformin Hcl | 337 | 51 |
| Memantine Hcl | Memantine Hcl | 316 | 50 |
| Buspirone Hcl | Buspirone Hcl | 289 | 54 |
| Januvia | Sitagliptin Phosphate | 281 | 29 |
| Divalproex Sodium | Divalproex Sodium | 238 | 41 |
| Memantine Hcl Er | Memantine Hcl | 218 | 19 |
| Pantoprazole Sodium | Pantoprazole Sodium | 218 | 66 |
| Myrbetriq | Mirabegron | 210 | 22 |
| Levetiracetam | Levetiracetam | 199 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 187 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 177 | 24 |
| Carvedilol | Carvedilol | 173 | 55 |
| Clopidogrel | Clopidogrel Bisulfate | 171 | 43 |
| Famotidine | Famotidine | 166 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 161 | 34 |
| Losartan Potassium | Losartan Potassium | 159 | 40 |
| Xarelto | Rivaroxaban | 158 | 16 |
| Baclofen | Baclofen | 152 | 24 |
| Spironolactone | Spironolactone | 125 | 28 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 119 | 41 |
| Oxcarbazepine | Oxcarbazepine | 118 | 15 |
| Tramadol Hcl | Tramadol Hcl | 118 | 49 |
| Galantamine Hbr | Galantamine Hbr | 115 | 15 |
| Sucralfate | Sucralfate | 115 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 105 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 100 | 51 |
| Hydrochlorothiazide | Hydrochlorothiazide | 99 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 97 | 21 |
| Metoclopramide Hcl | Metoclopramide Hcl | 95 | 17 |
| Lactulose | Lactulose | 94 | 40 |
| Jardiance | Empagliflozin | 92 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 91 | 26 |
| Ondansetron Hcl | Ondansetron Hcl | 90 | 61 |
| Nifedipine Er | Nifedipine | 88 | 23 |
| Hydralazine Hcl | Hydralazine Hcl | 87 | 25 |
| Simvastatin | Simvastatin | 86 | 16 |
| Omeprazole | Omeprazole | 85 | 31 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 80 | 21 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 79 | 15 |
| Trulicity | Dulaglutide | 78 | 11 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 77 | suppressed |
| Pregabalin | Pregabalin | 76 | 18 |
| Benztropine Mesylate | Benztropine Mesylate | 74 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 74 | 22 |
| Alendronate Sodium | Alendronate Sodium | 72 | 19 |
| Lorazepam | Lorazepam | 72 | 19 |
| Finasteride | Finasteride | 69 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 29 |
| Risperidone | Risperidone | 66 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 64 | 25 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 63 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 63 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 62 | 16 |
| Methocarbamol | Methocarbamol | 59 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 59 | 20 |
| Ingrezza | Valbenazine Tosylate | 58 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 58 | 54 |
| Enulose | Lactulose | 56 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 54 | 12 |
| Acetic Acid | Acetic Acid | 53 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 39 |
| Prednisone | Prednisone | 51 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 50 | 13 |
| Glipizide | Glipizide | 49 | 13 |
| Midodrine Hcl | Midodrine Hcl | 49 | 19 |
| Sevelamer Carbonate | Sevelamer Carbonate | 49 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 47 | 12 |
| Tradjenta | Linagliptin | 46 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | 26 |
| Levofloxacin | Levofloxacin | 44 | 30 |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 42 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 41 | 27 |
| Clonazepam | Clonazepam | 40 | suppressed |
| Latanoprost | Latanoprost | 40 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 39 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 31 |
| Gemtesa | Vibegron | 39 | suppressed |
| Olanzapine | Olanzapine | 39 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 38 | suppressed |
| Novolog | Insulin Aspart | 38 | 12 |
| Azithromycin | Azithromycin | 37 | 26 |
| Clotrimazole | Clotrimazole | 37 | 11 |
| Bumetanide | Bumetanide | 36 | suppressed |
| Cilostazol | Cilostazol | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 20 |
| Nuplazid | Pimavanserin Tartrate | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 12 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 33 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | 13 |
| Humalog | Insulin Lispro | 32 | 13 |
| Carbamazepine Er | Carbamazepine | 31 | suppressed |
| Celecoxib | Celecoxib | 31 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | 18 |
| Ondansetron Odt | Ondansetron | 30 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Alprazolam | Alprazolam | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 29 | suppressed |
| Calcitriol | Calcitriol | 28 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 24 |
| Allopurinol | Allopurinol | 27 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 18 |
| Clonidine | Clonidine | 27 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 27 | 16 |
| Paliperidone Er | Paliperidone | 27 | suppressed |
| Pentoxifylline | Pentoxifylline | 27 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 27 | 12 |
| Timolol Maleate | Timolol Maleate | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 27 | suppressed |
| Atenolol | Atenolol | 26 | suppressed |
| Brilinta | Ticagrelor | 26 | suppressed |
| Cephalexin | Cephalexin | 26 | 19 |
| Scopolamine | Scopolamine | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 25 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | suppressed |
| Lidocaine | Lidocaine | 23 | suppressed |
| Ketoconazole | Ketoconazole | 22 | 13 |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 22 | suppressed |
| Xifaxan | Rifaximin | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | 15 |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Nystop | Nystatin | 21 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 21 | 14 |
| Budesonide | Budesonide | 20 | 13 |
| Calcium Acetate | Calcium Acetate | 20 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 15 |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 19 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 19 | suppressed |
| Erythromycin | Erythromycin Base | 19 | 11 |
| Invega Sustenna | Paliperidone Palmitate | 19 | suppressed |
| Rivastigmine | Rivastigmine | 19 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 16 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Nystatin | Nystatin | 18 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 17 | 12 |
| Haloperidol | Haloperidol | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Cyclosporine | Cyclosporine | 16 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Dovato | Dolutegravir Sodium/Lamivudine | 15 | suppressed |
| Letrozole | Letrozole | 15 | suppressed |
| Levemir | Insulin Detemir | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 15 | 12 |
| Aptiom | Eslicarbazepine Acetate | 14 | suppressed |
| Cefdinir | Cefdinir | 14 | 13 |
| Cefuroxime | Cefuroxime Axetil | 14 | 12 |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | 13 |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Demeclocycline Hcl | Demeclocycline Hcl | 12 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 11 | suppressed |
| Sulfasalazine | Sulfasalazine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $227.20 · 2 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, NUPLAZID | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nuplazid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error